• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

EE12 Cost of Stroke Management in Turkey
This study aims to estimate stroke cost according to type and severity of stroke using the Health Benefit Schedule (SUT) and Ministry of Health (MoH) pharmaceutical price list among geographical distributions in Turkey.
Source: Value in Health - December 1, 2022 Category: International Medicine & Public Health Authors: E Arsava, E Yaka, AO Ozdemir, I Midi, A Eren, CK Akpinar, Y Kaya, C Sar Gedik Source Type: research

Budget Impact of Alteplase In Treatment of Acute Ischemic Stroke In Turkey
Cerebrovascular diseases are the sixth cause of total DALYs in Turkey and the Turkish Social Security Institution (SSI) faces a challenge on reimbursement decisions for treatment. Alteplase is a recombinant human tissue plasminogen activator indicated for treatment of acute ischemic stroke (AIS). Clinical trials have proved efficacy in reducing 90-day disability measured by the Modified Rankin Score (mRS) if administered within 4,5 hours of onset of symptoms. The agent is used as an addition to Standard of Care (SoC).
Source: Value in Health - October 1, 2017 Category: International Medicine & Public Health Authors: M Tatar, A Şentürk, E Tetik, L Yıldız, J Cheynel Source Type: research

PCR239 Physician and Patient Preferences for Oral Anticoagulation Therapy Decision-Making in Atrial Fibrillation: Results From a National Best-Worst Scaling Survey in Turkey (PREF-AF)
The objective of this study was to quantify the relative importance that patients and physicians in Turkey place on different OAC attributes when making treatment decisions in AF.
Source: Value in Health - December 1, 2022 Category: International Medicine & Public Health Authors: K Kilickesmez, D Aras, M Degertekin, N Ozer, B Hacibedel, K Helvacioglu, U Koc, A Olmez, O Ergene Source Type: research

Mobile Cardiac Monitorization Is A Cost-Effective Tool For The Diagnosis And Management Of Atrial Fibrillation Compared To Holter: A Cost Effectiveness Study In Turkey
Mobile Cardiac Monitorization (MCT) frequently detects paroxysmal atrial fibrillation (PAF) in patients with cryptogenic stroke and transient ischemic accident (TIA). Length of monitoring is strongly associated with detection of PAF, with an optimal monitoring period of at least 21 days. The diagnostic yield of patients monitored with MCT is 61%. This is significantly higher than that of patients who use the Event monitor (23%) or the Holter monitor (24%). The aim of the analysis is to conduct a cost-effectiveness analysis of MCT versus Holter monitorization, with direct cost and payer perspective in atrial fibrillation.
Source: Value in Health - October 1, 2017 Category: International Medicine & Public Health Authors: A Sharaf, H Ammar, G Kockaya, FB Yenilmez, D Akagunduz Akgul Source Type: research

Factors affecting organ donation rate during devastating brain injuries: a 6-year data analysis - Arslanta ş R, C Evik BE.
Objectives: The discrepancy between organ donation rate and the number of patients waiting transplantation has been a common problem in Turkey. Intracerebral hemorrhage (ICH), traumatic brain injury (TBI), anoxic encephalopathy, stroke, and brain tu...
Source: SafetyLit - January 8, 2020 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news